Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis

被引:13
作者
Bayliss, Julianne [1 ]
Randhawa, Roshnee [1 ]
Oh, Kyu-Bin [2 ]
Kandeil, Walid [3 ]
Jenkins, Victoria A. [3 ]
Turriani, Elisa [3 ]
Nissen, Michael [2 ]
机构
[1] GSK, Med Affairs, Melbourne, Vic, Australia
[2] GSK, Med Affairs, Singapore, Singapore
[3] GSK, Global Med Affairs, Wavre, Belgium
关键词
Pertussis; whooping cough; vaccination; adults; Australia; recommendations; general practitioners; survey; RISK-FACTORS; ADOLESCENTS;
D O I
10.1080/21645515.2020.1780848
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Adult vaccination in Australia is suboptimal. For instance, as few as one in nine people have received a pertussis vaccine in adolescence or adulthood, despite increasing disease burden and evidence of a positive correlation between older age and hospitalization rates. The objectives of this study were to describe general practitioners' (GPs) and adult consumers' knowledge and attitudes toward adult vaccination, with an emphasis on pertussis. Australian GPs and consumers were recruited in two nationally representative online surveys repeated annually between 2014 and 2018. Vaccination discussions occurred in a minority of adult/GP encounters. Pertussis was among the five most frequently identified vaccine preventable diseases but was unlikely to be proactively discussed with adults not in contact with young children. Among consumers, only one in three recalled ever receiving a pertussis vaccination. GPs are a strong predictor of adults receiving a pertussis vaccine. Possible factors contributing to low uptake are misconceptions around pertussis disease, vaccination requirements and lack of GP recommendation for adult vaccination. GPs have a key role to play in increasing adult vaccination coverage with their recommendation.
引用
收藏
页码:344 / 350
页数:7
相关论文
共 21 条
[1]  
American College of Physicians (ACP) in partnership with the Gerontological Society of America (GSA) and the American Pharmacists Association (APhA), 2017, AG IMM IMP ROL VACC
[2]  
[Anonymous], 2018, Australian Demographic Statistics
[3]  
[Anonymous], 2011, 2009 AD VACC SURV SU
[4]  
Australian Government, 2019, NAT IMM PROGR
[5]  
Australian Institute of Health and Welfare, 2018, CULT LING DIV POP
[6]  
Australian Technical Advisory Group on Immunisation (ATAGI), 2018, AUSTR IMM HDB
[7]  
Beard FH, 2015, COMMUN DIS INTELL, V39, pE329, DOI 10.33321/cdi.2015.39.37
[8]   A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults [J].
Booy, Robert ;
Van Der Meeren, Olivier ;
Ng, Su-Peing ;
Celzo, Froilan ;
Ramakrishnan, Gunasekaran ;
Jacquet, Jeanne-Marie .
VACCINE, 2010, 29 (01) :45-50
[9]   Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults [J].
Clarke, Michelle ;
Thomas, Natalie ;
Giles, Lynne ;
Marshall, Helen .
VACCINE, 2015, 33 (51) :7337-7343
[10]   Morbidity of pertussis in adolescents and adults [J].
De Serres, G ;
Shadmani, R ;
Duval, B ;
Boulianne, N ;
Déry, P ;
Fradet, MD ;
Rochette, L ;
Halperin, SA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :174-179